Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes

• Автори: Yuan Zou (Автор), Jing Zhang (Автор), Fei Sun (Автор), Qianqian Xu (Автор), Longmin Chen (Автор), Xi Luo (Автор), Ting Wang (Автор), Qing Zhou (Автор), Shu Zhang (Автор), Fei Xiong (Автор), Wen Kong (Автор), Ping Yang (Автор), Qilin Yu (Автор), Shiwei Liu (Автор), Cong-Yi Wang (Автор)
• Формат: Книга
• Опубліковано: BMC, 2024-02-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Abstract Background Fluvoxamine is one of the selective serotonin reuptake inhibitors (SSRIs) that are regarded as the first-line drugs to manage mental disorders. It has been also recognized with the potential to treat inflammatory diseases and viral infection. However, the effect of fluvoxamine on...